Table 5 The treatment outcomes in GBS and other bacterial septic arthritis group
Variable | All (231) | GBS group (87) | Other bacterial group (144) | P value |
|---|---|---|---|---|
Surgery (n, %) | 134, 58.0% | 54, 62.1% | 80, 55.6% | 0.331 |
Complication (n, %) | 132, 57.1% | 43, 49.4% | 89, 61.8% | 0.065 |
Death (n, %) | 38, 16.5% | 5, 5.7% | 33, 22.9% | < 0.001 |
Period of antibiotic treatment | ||||
Total course (days): Median (IQR25-IQR75) | 57.0 (42.0–109.0) | 60.0 (42.0–143.0) | 56.0 (42.0–102.0) | 0.287 |
Intravenous form (days): Median (IQR25-IQR75) | 29.0 (21.0–42.0) | 28.0 (19.0–37.0) | 30.0 (21.0–45.0) | 0.134 |
Oral form (days): Median (IQR25-IQR75) | 30.0 (8.0–76.0) | 34.5 (17.0–98.0) | 28.0 (0.0–60.0) | 0.007 |
Length of stay (days): Median (IQR25-IQR75) | 29.0 (18.0–42.0) | 27.0 (19.0–38.0) | 31.0 (18.0–47.0) | 0.378 |